α-glucosidase inhibitors from the leaves and stems of Erythrina Variegata L. collected in Hanoi
##plugins.themes.academic_pro.article.main##
Author
-
Phi-Hung NguyenInstitute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), VietnamSavanchith XayavongFaculty of Chemistry, Hanoi National University of Education, VietnamNgoc-Thao-Vy TrinhUniversity of Medicine and Pharmacy at Ho Chi Minh City (UMP HCM); Faculty of Medicine and Pharmacy, Tay Nguyen University, VietnamDang Ngoc QuangFaculty of Chemistry, Hanoi National University of Education, VietnamLe Thi Phuong HoaFaculty of Biology, Hanoi National University of Education, VietnamThi-Thuy DoInstitute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), VietnamThi-Ha VuInstitute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), VietnamThi-Thuc BuiInstitute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), VietnamThi-Thu-Ha TrinhInstitute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), Vietnam
Từ khóa:
Erythrina variegata
α-glucosidase inhibitor
anti-diabetic
anti-obesity
Vong nem
Tóm tắt
Four secondary metabolites, including daidzein (1), genistein (2), glycitein (3), and daidzin (4) have been isolated and structural elucidated from the methanolic extract of the stems and leaves of Erythrina variegata L. collected in Hanoi city, Vietnam. These compounds showed good in vitro inhibition on α-glucosidase enzyme with IC50 values of 97.6 ± 0.6, 230.4 ± 0.4, 34.3 ± 0.9, and 217.2 ± 0.2 µM, respectively as compared with that of acarbose (IC50 value of 125.8 ±
1.2 µM). This finding suggests the possible application of product containing high content of these compounds from the leaves and stems of E. variegata L. for research and development of anti-obese agent.
Tài liệu tham khảo
-
[1] V. Chi, “Dictionary of Medicinal Plants in Vietnam”. Medical Publishing House, Hanoi, 2012.
[2] T. Loi, “Medicinal Plants and Remedies of Vietnam”. Hanoi, Vietnam, Publishing House Medicine, 2001.
[3] S. Chawla, T. R. Krishnan, A. H. Jackson, and D. A. Scalabrin, “Alkaloidal Constituaents of Erythrina variegata Bark”, Planta Medica, Vol. 54, no. 6, pp. 526-528, 1988.
[4] Cui, P. T. Thuong, Z. T. Fomum, and W. K. Oh, “A new Erythrina Alkanoid from the Seed of Erythrina addisoniae”, Archieves of Pharmacal Reserch, Vol. 32, pp. 325-328, 2009.
[5] L. Liu, S. S. Chu, G. H. Jiang, and S. L. Liu, “Antifeedants from Chinese Medicinal Herb, Erythrina variegata var. orientalis, Against Maize Weevil Sitophilus zeamai”, Natural Product Communications, Vol. 7, no. 2, pp. 171-172, 2012.
[6] Sato,H. Tanaka,S. Fujiwara,M. Hirata,R. Yamaguchi; H. Etoh,and C. Tokuda,“Antibacterial property of isoflavonoids isolated from Erythrina variegata against cariogenic oral bacteria”, Phytomedicine, Vol. 10, no. 5, pp. 427-433, 2003.
[7] Kurebayashiet al., “Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6”, British Journal of Cancer, Vol. 79, no. 5-6, pp. 707-717, 1999.
[8] T. Tang, J. Wu, Y. Yu, M. F. Bao, Q. G. Tan, J. Schinnerl, and X. H. Cai, “Colored Dimeric Alkaloids from the Barks of Erythrina variegata and Their Neuroprotective Effects”, J. Org. Chem., Vol. 86, pp. 13381–13387, 2021.
[9] T. Tang, J. Wu, Y. Yu, M. F. Bao, Q. G. Tan, and X. H. Cai, “Dimeric Erythrina alkaloids as well as their key units from Erythrina variegate”, Phytochemistry, Vol. 198, pp. 113160–113167, 2022.
[10] T. Tang, Z. R. Si, M. F. Bao, and X. H. Cai, “Dimeric alkaloids from the barks of Erythrina variegata as well as their occurrence”, Fitoterapia, Vol. 166, pp. 105408–105417, 2023.
[11] J. Zhang, J. Wu, M. F. Bao, F. Wang, and X. H. Cai, “Artificial Erythrina Alkaloids from Three Erythrina Plants, E. variegata,
E. cristagalli and E. arborescens. Natural Products and Bioprospecting”, Vol. 10, pp. 57–66, 2020.
[12] D. Samanta and S. Laskar, “Review on Erythrina variegata LINN”, World Journal of Pharmaceutical Research, Vol. 8, no. 3, pp. 540–591, 2019.
[13] Martins and S. Brijesh, “Anti-depressant activity of Erythrina variegata bark extract and regulation of monoamine oxidase activities in mice”, Journal of Ethnopharmacology, Vol. 248, pp. 112280–112291, 2020.
[14] Zhang et al., “Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats’, Journal of Ethnopharmacology, Vol. 109, pp. 165–169, 2007.
[15] Herlina, U. Supratman, U. M. S. Soedjanaatmadja, A. Subarnas, S. Sutardjo, N. R. Abdullah, and H. Hayashi, “Anti-malarial compounds from the stem bark of Erythrina variegata”, Indo. J. Chem., Vol. 9, no. 2, pp. 308–311, 2009.
[16] W. H. Kousar, M. Veeraragavan, and P. Saranraj, “Larvicidal activity of Pedalium murex and Erythrina variegata methanol extract against mosquito vectors: A comparative study, The Pharma. Innovation Journal, Vol. 8, no. 4, pp. 889–892, 2019.
[17] Haque, M. S. Ali, A. Saha, and Md. Alimuzzaman, “Analgesic Activity of Methanolic Extract of the Leaf of Erythrina variegata”, Dhaka Univ. J. Pharm. Sci. Vol. 5, no. 1-2, pp. 77–79, 2006.
[18] Venkateswarlu, G. V. Durga, N. Ch. Babu, and M. V. Rao, “Biosorption of Zn(II) from an aqueous solution by Erythrina variegata orientalis leaf powder”, International Journal of Physical Sciences, Vol. 3, no. 9, pp. 197–204, 2008.
[19] T. Sangale, D. B. Deshmukh, and R. Bhambere, “Anticonvulsant Effect of Leaf and Bark of Erythrina Variegata Linn. and Butea Monosperma (LAM) Taub in different Experimental Convulsion Model in Rats. PharmaTutor, Vol. 3, no. 5, pp. 19–23, 2015.
[20] C. Nagar and L. S. Chauhan, “Antihyperglycemic and antihyperlipidemic activity of root extracts of Erythrina variegata in stroptozotocin induced diabetic rats”, World Journal of Pharmaceutical Research, Vol. 5, no. 2, pp. 1322–1332, 2016.
[21] Santhiya, S. Priyanga, S. Hemmalakshmi, and K. Devaki, “Phytochemical analysis, Anti-inflammatory activity, in vitro antidiabetic activity and GC-MS profile of Erythrina variegata L. bark”, Journal of Applied Pharmaceutical Science, Vol. 6, no. 07, pp. 147–155, 2016.
[22] Kumar, S. Lingadurai, T. P. Shrivastava, S. Bhattacharya, and P. K. Haldar, “Hypoglycemic activity of Erythrina variegata leaf in streptozotocin-induced diabetic rats”, Pharmaceutical Biology, Vol. 49, no. 6, pp. 577–582, 2011.
[23] C. To et al., “On the Inhibitability of Natural Products Isolated from Tetradium ruticarpum towards Tyrosine Phosphatase 1B (PTP1B) and α-glucosidase (3W37): an in vitro and in silico Study”, Molecules, Vol. 26, pp. 3691–3708, 2021.
[24] H. Kim, K. U. Yu, E. A. Bae, and M. J. Han, “Metabolism of Puerarin and Daidzin by Human Intseinal Bacteria and Their Relation to in Vitro Cytotoxicity”, Biol. Pharm. Bull., Vol. 21, no. 6, pp. 628–630, 1998.
[25] Q. Ma, G. J. Zheng, and Y. Zhangetal, “Antiosteoporotic flavonoids from Podocarpium podcarpum”, Phytochemistry Letters, Vol. 6, pp. 118–112, 2013.
[26] Y. Sung, J.C.S. Rha, and M. Y. Baik, “A brief history and spectroscopic analysis of soy isofla vones”, Food Sci Biotechnol, vol. 29, pp. 1605–1617, 2000.
[27] S. Kudou, Y. Fleury, D. Welti, D. Magnolato, T. Uchida, K. Kitamura, and K. Okubo, “Malonyl isoflavone glycosides in Soybean Seeds (Glycine max Merrill)”, Agric.Biol. Chem, Vol. 55, no. 9, pp. 2229–2233, 1991.
Xem thêm
Ẩn bớt
##plugins.themes.academic_pro.article.sidebar##
Đã Xuất bản
Jun 30, 2023
Download
Cách trích dẫn
Nguyen, P.-H., S. Xayavong, N.-T.-V. Trinh, D. N. Quang, L. T. P. Hoa, T.-T. Do, T.-H. Vu, T.-T. Bui, và T.-T.-H. Trinh. “α-Glucosidase Inhibitors from the Leaves and Stems of Erythrina Variegata L. Collected in Hanoi”. Tạp Chí Khoa học Và Công nghệ - Đại học Đà Nẵng, vol 21, số p.h 6.1, Tháng Sáu 2023, tr 71-74, doi:10.31130/ud-jst.2023.040E.